Merck Animal Health, referred to as MSD Animal Health outside the U.S. and Canada, a branch of Merck & Co., Inc., Rahway, New Jersey, USA, revealed that the US Food and Drug Administration (FDA) has provided conditional approval for Exzolt Cattle-CA1
Drug-maker Lupin said on December 5, 2025, that it has received tentative approval from the US Food and Drug Administration (USFDA) for its generic version of Siponimod Tablets. The approved strengths are 0.25 mg, 1 mg, and 2 mg. These tablets...
The Establishment Inspection Report (EIR) issued to Zydus Lifesciences by the U.S. Food and Drug Administration (USFDA) concerning the GMP follow-up inspection at its injectable manufacturing facility in Jarod, Vadodara. This audit was carried out be
.jpeg "Granules Consumer Health Clears USFDA Inspection with Zero Observation")
Granules India reported that its subsidiary in the U.S., with step-down operations, Granules Consumer Health, LLC, has passed a Good Manufacturing Practice (GMP) inspection conducted by the U.S. Food and Drug Administration (FDA) with zero observatio
Sanofi has completed the acquisition of Vicebio Ltd, and this will make it stronger in the vaccine portfolio and prove its role as an innovative biopharma leader. The acquisition combines an exciting early-stage combination vaccine against...
Astrazeneca's presence at the 2025 ASH Annual Meeting is the largest sharpe in the history of ASH and represents Astrazeneca's continuing efforts to lead the way in haematology. The company's 65 abstracts represent an impressive milestone across...
Global pharma leader Lupin has taken a major step forward in the U.S. biosimilar market with a new exclusive licensing agreement for Armlupeg (pegfilgrastim-unne). The company announced today that it has partnered with Valorum Biologics, a...
Pharma company Corona Remedies, supported by private equity firm ChrysCapital, has set a price range of Rs 1,008-1,062 per share for its forthcoming Initial Public Offering (IPO), which values the firm at approximately Rs 6,500 crore
AptarGroup, a worldwide leader in dosing, dispensing, and protection technologies for drugs and consumer products, has revealed the purchase of Sommaplast, a Brazil-based company that specializes in oral dosing pharmaceutical packaging solutions
Tata 1mg and OneBanc have forged a strategic partnership aimed at revolutionizing India’s corporate healthcare sector, a market valued at over Rs. 12,000 crore annually across diagnostics, outpatient services, and preventive wellness
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")